HOXC-AS3: A Potential Drug Target and Biomarker (G100874365)

Target Name: HOXC-AS3

NCBI ID: G100874365

HOXC-AS3

Other Name(s): HOXC cluster antisense RNA 3

HOXC-AS3: A Potential Drug Target and Biomarker

Hoxc-AS3, a protein encoded in the gene HOXC-AS3, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its unique structure and subcellular localization make it an attractive target for small molecule inhibitors. In this article, we will discuss the biology of Hoxc-AS3, its potential drug targets, and its potential as a biomarker for disease.

Biography of Hoxc-AS3

Hoxc-AS3 is a 25 kDa transmembrane protein that is expressed in various tissues, including brain, heart, and muscle. Its protein is composed of 251 amino acids and has a calculated pI of 9.6. Hoxc-AS3 is highly homogeneous and has a monomeric structure. It is expressed in various tissues and has been shown to play a role in various physiological processes, including cell signaling, tissue repair, and inflammation.

Potential Drug Targets

HOXC-AS3 is a potential drug target due to its unique structure and localization in the cell membrane. Its transmembrane nature and subcellular localization make it an attractive target for small molecule inhibitors. Several studies have shown that Hoxc-AS3 is involved in various cellular processes, including cell signaling, migration, and invasion. Therefore, inhibitors that can modulate its activity could be useful for treating various diseases.

In addition to its involvement in cell signaling, Hoxc-AS3 has also been shown to play a role in tissue repair and regeneration. Its expression has been observed in various tissues after injury or disease, including muscle, heart, and brain. Therefore, Hoxc-AS3 may be a promising target for tissue repair and regeneration therapies.

Potential Biomarker

HOXC-AS3 may also be used as a biomarker for various diseases. Its unique structure and localization make it an attractive target for small molecule inhibitors, which can be used to detect changes in its expression levels. Several studies have shown that Hoxc-AS3 is involved in various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Therefore, its expression levels can be used as a biomarker for these diseases.

In conclusion, Hoxc-AS3 is a protein that has potential as a drug target and biomarker for various diseases. Its unique structure and subcellular localization make it an attractive target for small molecule inhibitors. Further studies are needed to fully understand its role in various diseases and to develop effective treatments.

Protein Name: HOXC Cluster Antisense RNA 3

The "HOXC-AS3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HOXC-AS3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets